Renaissance Technologies Portfolio holdings
Renaissance Technologies is a hedge fund firm that trades with computer models built on mathematics and statistics. It began in 1978 as Monemetrics, founded by Jim Simons, a mathematician and former Cold War codebreaker, and took its current name in 1982. The firm launched its Medallion Fund in 1988 and staffs its research with mathematicians, statisticians, physicists, astronomers and computer scientists. Medallion trades over short time spans across many asset types, and it has been closed to outside investors since 1993, open only to current and past employees and their families.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Merck
MRK
|
+$468M |
| 2 |
Johnson & Johnson
JNJ
|
+$440M |
| 3 |
IBM
IBM
|
+$355M |
| 4 |
Booking.com
BKNG
|
+$332M |
| 5 |
RAI
Reynolds American Inc
RAI
|
+$331M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
LLTC
Linear Technology Corp
LLTC
|
+$482M |
| 2 |
Walt Disney
DIS
|
+$247M |
| 3 |
Visa
V
|
+$219M |
| 4 |
Deere & Co
DE
|
+$200M |
| 5 |
Johnson Controls International
JCI
|
+$179M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 15.75% |
| 2 | Technology | 13.82% |
| 3 | Financials | 12.86% |
| 4 | Industrials | 9.93% |
| 5 | Consumer Staples | 9.58% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
1
Johnson & Johnson
JNJ
$665B
| $885M | 1.24% |
7,102,700
+3,679,600
| +107% | +$440M |
2015 Q3
6 quarters
|
|
2
NetEase
NTES
$72.8B
| $645M | 0.9% |
11,348,500
+1,279,000
| +13% | +$68.9M |
2013 Q2
15 quarters
|
|
3
Mastercard
MA
$554B
| $591M | 0.83% |
5,252,700
-388,700
| -7% | -$42.6M |
2013 Q2
15 quarters
|
|
4
Novo Nordisk
NVO
$176B
| $563M | 0.79% |
32,818,400
+4,926,600
| +18% | +$85.8M |
2013 Q2
15 quarters
|
|
5
Humana
HUM
$49.7B
| $555M | 0.78% |
2,691,700
+1,231,400
| +84% | +$255M |
2015 Q2
7 quarters
|
|
6
Gilead Sciences
GILD
$213B
| $523M | 0.73% |
7,707,248
+2,432,300
| +46% | +$171M |
2014 Q4
9 quarters
|
|
7
Colgate-Palmolive
CL
$76.3B
| $501M | 0.7% |
6,849,600
-1,604,000
| -19% | -$112M |
2013 Q2
15 quarters
|
|
8
PepsiCo
PEP
$188B
| $486M | 0.68% |
4,343,800
+2,067,338
| +91% | +$222M |
2013 Q2
15 quarters
|
|
|
9
Merck
MRK
$368B
| $468M | 0.65% |
+7,716,460
| New | +$468M |
2017 Q1
0 quarters
|
|
10
NVIDIA
NVDA
$4.98T
| $435M | 0.61% |
159,623,720
+35,835,720
| +29% | +$95.4M |
2013 Q4
13 quarters
|
|
|
AET
11
DELISTED
Aetna Inc
AET
| $397M | 0.55% |
3,111,482
+268,700
| +9% | +$33.7M |
2015 Q3
6 quarters
|
|
12
Amgen
AMGN
$254B
| $396M | 0.55% |
2,413,445
+634,800
| +36% | +$105M |
2013 Q2
15 quarters
|
|
13
Domino's
DPZ
$10.3B
| $393M | 0.55% |
2,130,700
+517,200
| +32% | +$92.6M |
2013 Q2
15 quarters
|
|
14
Crown Castle
CCI
$38.1B
| $378M | 0.53% |
3,998,603
+1,043,700
| +35% | +$93.4M |
2015 Q1
8 quarters
|
|
15
Walmart Inc
WMT
$979B
| $364M | 0.51% |
15,130,200
+3,252,900
| +27% | +$74.9M |
2016 Q1
4 quarters
|
|
16
Cboe Global Markets
CBOE
$35.1B
| $362M | 0.51% |
4,467,300
+81,200
| +2% | +$6.35M |
2013 Q2
15 quarters
|
|
|
17
Booking.com
BKNG
$113B
| $358M | 0.5% |
+5,029,975
| New | +$332M |
2017 Q1
0 quarters
|
|
18
VeriSign
VRSN
$28B
| $358M | 0.5% |
4,104,376
-159,000
| -4% | -$13.2M |
2013 Q2
15 quarters
|
|
|
19
IBM
IBM
$242B
| $352M | 0.49% |
+2,116,790
| New | +$355M |
2017 Q1
0 quarters
|
|
20
Bristol-Myers Squibb
BMY
$128B
| $352M | 0.49% |
6,468,000
+5,871,000
| +983% | +$322M |
2016 Q2
3 quarters
|
|
|
RAI
21
DELISTED
Reynolds American Inc
RAI
| $348M | 0.49% |
5,514,535
+5,503,235
| +48,701% | +$331M |
2015 Q3
6 quarters
|
|
22
Costco
COST
$448B
| $317M | 0.44% |
1,891,800
-927,913
| -33% | -$156M |
2013 Q2
15 quarters
|
|
23
Meta Platforms (Facebook)
META
$1.62T
| $313M | 0.44% |
2,201,800
+2,141,800
| +3,570% | +$286M |
2015 Q4
5 quarters
|
|
24
Sherwin-Williams
SHW
$80.3B
| $298M | 0.42% |
2,885,700
+1,907,700
| +195% | +$192M |
2013 Q2
15 quarters
|
|
25
American Electric Power
AEP
$71.4B
| $294M | 0.41% |
4,383,800
+496,200
| +13% | +$32.1M |
2014 Q3
10 quarters
|
|
Similar funds
Renaissance Technologies's Q1 2017 Portfolio in Review
As of Q1 2017, Renaissance Technologies held 3,652 positions worth $71.6B, up 13% from $63.2B the previous quarter. Its ten largest holdings account for 7.9% of the portfolio.
Renaissance Technologies deployed $5.19B of net new capital in Q1 2017, opening 433 new positions and adding to 1,584 existing holdings. Its largest new stake was Merck: 7,716,460 shares worth $468M.
By sector, the portfolio is most concentrated in Healthcare at 16% of assets, up from 13% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Walt Disney, an estimated $247M trimmed.
- Renaissance Technologies's largest Q1 2017 buy was Merck: 7,716,460 shares worth $468M.
- Renaissance Technologies added most to Johnson & Johnson in Q1 2017, an estimated $440M increase.
- Renaissance Technologies's biggest Q1 2017 reduction was Walt Disney, cutting an estimated $247M.
- Renaissance Technologies fully exited Linear Technology Corp in Q1 2017, selling an estimated $482M.
- Renaissance Technologies's ten largest holdings make up 7.9% of its $71.6B portfolio in Q1 2017.
- Renaissance Technologies opened 433 new positions and closed 462 in Q1 2017.
- Renaissance Technologies's portfolio value rose 13% quarter-over-quarter to $71.6B.
Based on Renaissance Technologies's 13F filing for Q1 2017, filed 12 May 2017.